TechSurge: The Deep Tech VC Podcast

In this episode, we explore the future of mobility and AI with Aicha Evans, CEO of Zoox, a leading developer of autonomous robotaxis and an Amazon company. Joining Celesta Capital’s founding partner Sriram Viswanathan, Aicha shares her journey from Senegal to Silicon Valley, where she led groundbreaking innovations at Intel before taking the helm at Zoox.

Together, they discuss the challenges and opportunities in autonomous transportation, the evolving role of AI in various industries, and the critical importance of safety, customer experience, and scaling in the robotaxi space.

Tune in for insights on the future of transportation and the transformative potential of AI in shaping our daily lives.

Will AI will take away all of our jobs? Is technology eroding privacy? Is the pace of technology advancement too fast?

‍We address these questions and more topics around global science and technology policy with Rob Atkinson, founder and president of the Information Technology and Innovation Foundation. Speaking with Celesta Capital founding partner Nic Brathwaite, Rob dives into the intersection of technology, innovation, and public policy, covering topics such as ethical AI, the role of China in the global innovation race, and the realities facing smaller economies in blossoming into tech hubs. Rob shares his insights on innovation economics, government policy, and the critical role of entrepreneurs in shaping the future of tech.

Fred Thiel, Chairman and CEO of Marathon Digital, dives us into the world of blockchain and cryptocurrency mining. Fred discusses the technological advancements in Bitcoin mining, including significant improvements in energy efficiency, and provides insights into the future of Bitcoin, predicting substantial growth in its value and its linkages with AI inference data centers. He also explains the relationship between Bitcoin and global economic factors, the potential for regulatory changes, and the evolving role of cryptocurrencies in both developed and developing markets, highlighting Bitcoin’s growing role as a store of value and a driver of financial sovereignty in the digital age.

Micron CEO Sanjay Mehrotra discusses his journey in the semiconductor industry and the growing strategic importance of the memory industry in the age of AI. He highlights innovation in high bandwidth memory (HBM), which enables faster data access and lower power consumption. Sanjay also discusses Micron’s plans to build new U.S. semiconductor factories and the role of the CHIPS Act in bringing semiconductor manufacturing back to the U.S. He shares his insights on the resurgence of hardware innovation and what it takes to drive technological leadership in a rapidly evolving industry.

Former CEO of PepsiCo and New York Times bestselling author Indra Nooyi joins host Michael Marks for a wide-ranging conversation to share her insights on the growth of big tech companies, the impact of AI, CEO-board relationships, and much more.

Indra currently serves on the boards of Amazon, Phillips, Memorial Sloan Kettering Cancer Center, the National Gallery of Art, and is a Dean’s Advisory Council Member at MIT School of Engineering. Her New York Times bestselling memoir My Life In Full offers insight and a call-to-action from one of the world’s most-admired business leaders on how our society can blend work and family — and advance women — in the 21st century. She is widely considered to be one of the world’s top CEOs for her leadership at global giant PepsiCo over 12 years.

Driven both by surging demand and rapid technology advancements, an emerging area of health innovation called “bioconvergence” is driving improvements in human health and sustained interest from investors. This episode will explore these new applications merging engineered technologies with scientific disciplines, including in diagnostics, therapeutics, and elsewhere.

Nobel Laureate Dr. Jim Rothman, Dr. Melanie Mathieu of Prellis Biologics, and Daniel Dornbusch of Excision join host Michael Marks for an in-depth discussion covering advancements in CRISPR technology, the role of AI in drug discovery, the future of personalized medicine, and much more.